Dazzling Tecfidera makes its Indian debut

Biogen Idec has announced launch plans in India for Tecfidera (dimethyl fumarate) – the first oral therapy for remitting multiple sclerosis (RRMS) in the country.

Biogen Idec has announced launch plans in India for Tecfidera (dimethyl fumarate) – the first oral therapy for remitting multiple sclerosis (RRMS) in the country.

Biogen's Indian affiliate said that it received approval for the product from the Drugs Controller General of India and that...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Neurological

More from Therapeutic Category